Avatar

Zodasiran Silences Hepatic ANGPTL3 Leading to Deep and Durable Reduction in Atherogenic Lipids and Lipoproteins in Mixed Dyslipidemia Patients - Final Results from ARCHES-2 Trial

By Robert Rosenson 3 Videos
189 views
June 6, 2024

Chapters

Introduction & Background on Angiopoietin-like 3

00:00

ARCHES-2 Trial Design & Objectives

02:27

Study Population Characteristics

04:49

Efficacy Results & Lipid Profile Improvements

05:58

Safety Profile & Summary of Findings

07:33

1 Comment
Login to view comments. Click here to Login

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Featured Video

05:11
Novartis Cardiology

Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Th…

Feat. R. Sugumaran, P. Shah, S. Shugg

Related Content

AUTOPLAY
16:57
William White

Ambulatory Blood Pressure Monitoring

42:28
Scripps Health

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Feat. M. Budoff
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
21:34
Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
19:16
The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
34:20
Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
28:05
Michael Makover

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar
31:27
Scripps Health

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Feat. N. Lepor
19:48
ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano
15:50
European Menopause and Andropause Society

Effects of Menopause Hormone Treatment on Atherosclerosis Progression

Feat. E. Armeni
54:16
Georgia Heart Institute

Coronary Calcification: Basic Mechanisms, Research Applications, and…

Feat. K. Watson
21:48
Canadian Collaborative Research Network

I Ordered an Lp(a) Level – Now What?

Feat. M. O'Donoghue